Regarding Insulin Initiation in Type 2 Diabetes Mellitus and the Risk for Hypoglycemia

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F18%3A10375515" target="_blank" >RIV/00216208:11130/18:10375515 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/18:10375515

Výsledek na webu

<a href="https://doi.org/10.1016/j.jcjd.2017.07.001" target="_blank" >https://doi.org/10.1016/j.jcjd.2017.07.001</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jcjd.2017.07.001" target="_blank" >10.1016/j.jcjd.2017.07.001</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Regarding Insulin Initiation in Type 2 Diabetes Mellitus and the Risk for Hypoglycemia

Popis výsledku v původním jazyce

We read with interest the review article by Jaqueline Smith, &quot;Practical Tips for Insulin Use in Primary Care&quot; that has been published in the Canadian Journal of Diabetes. It provides a useful outline of the basic framework for the initiation of insulin therapy in people with type 2 diabetes who have failed on oral antidiabetes therapy and how prandial and basal insulins can be used. While the risk of hypoglycemia is mentioned, it is introduced primarily as a potential barrier to the initiation of insulin therapy from the viewpoint of the patient as user and the medical practitioner as provider, with only a cursory mention of the risks associated with various insulin preparations.

Název v anglickém jazyce

Regarding Insulin Initiation in Type 2 Diabetes Mellitus and the Risk for Hypoglycemia

Popis výsledku anglicky

We read with interest the review article by Jaqueline Smith, &quot;Practical Tips for Insulin Use in Primary Care&quot; that has been published in the Canadian Journal of Diabetes. It provides a useful outline of the basic framework for the initiation of insulin therapy in people with type 2 diabetes who have failed on oral antidiabetes therapy and how prandial and basal insulins can be used. While the risk of hypoglycemia is mentioned, it is introduced primarily as a potential barrier to the initiation of insulin therapy from the viewpoint of the patient as user and the medical practitioner as provider, with only a cursory mention of the risks associated with various insulin preparations.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Canadian Journal of Diabetes

ISSN

1499-2671

e-ISSN

—

Svazek periodika

42

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CA - Kanada

Počet stran výsledku

1

Strana od-do

221

Kód UT WoS článku

000433427400001

EID výsledku v databázi Scopus

2-s2.0-85028354968